Does LANADELUMAB-FLYO Cause Product dose omission issue? 177 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 177 reports of Product dose omission issue have been filed in association with LANADELUMAB-FLYO. This represents 11.9% of all adverse event reports for LANADELUMAB-FLYO.
177
Reports of Product dose omission issue with LANADELUMAB-FLYO
11.9%
of all LANADELUMAB-FLYO reports
4
Deaths
92
Hospitalizations
How Dangerous Is Product dose omission issue From LANADELUMAB-FLYO?
Of the 177 reports, 4 (2.3%) resulted in death, 92 (52.0%) required hospitalization, and 12 (6.8%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANADELUMAB-FLYO. However, 177 reports have been filed with the FAERS database.
What Other Side Effects Does LANADELUMAB-FLYO Cause?
Hereditary angioedema (794)
Inappropriate schedule of product administration (144)
Drug ineffective (137)
Headache (126)
Weight decreased (125)
Weight increased (120)
Injection site pain (119)
Product use issue (114)
Malaise (90)
Nausea (77)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which LANADELUMAB-FLYO Alternatives Have Lower Product dose omission issue Risk?
LANADELUMAB-FLYO vs LANREOTIDE
LANADELUMAB-FLYO vs LANSOPRAZOLE
LANADELUMAB-FLYO vs LANTHANUM
LANADELUMAB-FLYO vs LANTUS
LANADELUMAB-FLYO vs LANTUS SOLOSTAR